| Kdmc Pediatric Adolescent Clinic | |
|
509 Brookman Dr. Brookhaven MS 39601-2326 | |
| (601) 823-5204 | |
| Not Available |
| Full Name | Kdmc Pediatric Adolescent Clinic |
|---|---|
| Speciality | Clinic/center - Rural Health |
| Location | 509 Brookman Dr., Brookhaven, Mississippi |
| Authorized Official Name and Position | Scott Christensen (CEO) |
| Authorized Official Contact | 6018359488 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Kdmc Pediatric Adolescent Clinic 427 Highway 51 N Brookhaven MS 39601-2350 Ph: (601) 835-9275 | Kdmc Pediatric Adolescent Clinic 509 Brookman Dr. Brookhaven MS 39601-2326 Ph: (601) 823-5204 |
| NPI Number | 1275307902 |
|---|---|
| Provider Enumeration Date | 11/13/2023 |
| Last Update Date | 11/13/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275307902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
As a minimally invasive method for cancer therapy at precise locations, NIR-induced photothermal therapy (PTT) has drawn extensively attention. The therapeutic mechanism is the use of photothermal agents (PTAs) in the treatment of tumors,and its therapeutic effect happens only at the tumor site where both light-absorbent and localized laser radiation coexist.
› Verified 5 days ago
King's Daughters Primary Care Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 940 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-823-5000 | |
King's Daughters Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 950 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-7973 | |
Joseph S Moak Jr Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1040 Biglane Drive, Brookhaven, MS 39601 Phone: 601-833-5051 Fax: 601-835-0240 | |
Doctors Urgent Care, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 439 N Jackson St, Suite A, Brookhaven, MS 39601 Phone: 601-833-9912 | |
Extended Care Clinical Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 724 N Jackson St, Brookhaven, MS 39601 Phone: 601-412-4503 | |
Alexander Jr. High School Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Alexander Jr High School, 713 Beauregard St., Brookhaven, MS 39601 Phone: 601-833-7549 Fax: 601-835-5467 |